AzTrials
AzTrials

ObesityNCT07144800

Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)

A study testing Parent Weekly Individual Telephone Support, Child Education and Parent Initial Counseling in people with Obesity and Child Obesity, run by Memorial Sloan Kettering Cancer Center at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this study is to determine the most effective family-centered intervention (FCI) for weight loss and obesity prevention in Hispanic families. FCI is a type of program that involves family (such as parents and caregivers) supporting their children to promote healthy habits. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Obesity, Child Obesity, Weight Loss
What is being tested?
Parent Weekly Individual Telephone Support, Child Education and Parent Initial Counseling
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,319 participants
Where
1 siteUnited States
Study dates
22 Aug 2025to 31 Jul 2031
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Phase 1
  • Age >= 18 years (per self-report)
  • Self-identifies as Hispanic/Latino (per self-report)
  • Seeking, or has used, services at the VDS or MHU (per self-report)
  • Is the parent or primary caregiver for at least one child aged 8-12 living in their household (per self-report)
  • Screens as obese (BMI > 30 kg/m2) or overweight (BMI of 25 - 29.9 kg/m2) (per height and weight measurement in person or per self-report)
Show all 21Show fewer
  • Owns a cell phone capable of receiving text messages (per self-report)
  • Owns an internet connected device (e.g. cell phone, tablet, etc.) capable of conducting videoconference calls (per self-report)
  • Agrees to be audio-recorded (per self-report)
  • Phase 2 (parent participants)
  • Age >= 18 years (per self-report)
  • Self-identifies as Hispanic/Latino (per self-report)
  • Seeking, or has used, services at the VDS or MHU (per self-report)
  • Is the parent or primary caregiver for at least one child aged 8-12 living in their household (per self-report)
  • Screens as obese (BMI > 30 kg/m2) or overweight (BMI of 25 - 29.9 kg/m2) (per height and weight measurement in person or remotely)
  • Owns a cell phone capable of receiving text messages (per self-report)
  • Owns an internet connected device (e.g. cell phone, tablet, etc.) capable of conducting videoconference calls (per self-report)
  • Agrees to be audio-recorded (per self-report)
  • Phase 2 (child participants)
  • Age 8-12 years (per parent self-report)
  • Has a parent or primary caregiver who is eligible and participating in Phase 2 (per parent self-report)

Who cannot join

  • Phase 1
  • Is pregnant or might be pregnant (per self-report)
  • Presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with hypertension and diabetes mellitus may still participate) that may affect diet and study participation (per self-report)
  • Has dietary restrictions, i.e. liquid diet, that may affect diet and study participation (per self-report)
  • Has a household member who has already participated or agreed to participate in this study program (per self-report)
  • Prior participation in one of our preliminary studies, e.g., COMIDA, SANOS, Family COMIDA (per self-report) and any related focus groups
Show all 25Show fewer
  • Works for or with the VDS or MHU (per self-report)
  • Presence of cognitive impairment disorder (i.e., delirium or dementia) sufficient to preclude meaningful informed consent and/or data collection (per study team)
  • Phase 2 (parent participant)
  • Is pregnant or might be pregnant (per self-report)
  • For women, is lactating (per self-report)
  • Presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with hypertension and diabetes mellitus may still participate) that may affect diet and study participation (per self-report)
  • Has dietary restrictions, i.e., liquid diet, that may affect diet and study participation (per self-report)
  • Has physical activity restrictions, i.e., handicapped or mobility issues, that may affect physical activity participation (increasing step counts; per self-report)
  • Has a household member who has already participated or agreed to participate in this study program (per self-report)
  • Prior participation in one of our preliminary studies, e.g., COMIDA, SANOS, Family COMIDA (per self-report) and any related focus groups
  • Works for or with the VDS or MHU (per self-report)
  • Presence of cognitive impairment disorder (i.e., delirium or dementia) sufficient to preclude meaningful informed consent and/or data collection (per study team)
  • Has been prescribed Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity (or other GLP 1 receptor agonist), or any other drug to treat obesity (per self-report) or (if previously prescribed) 7 weeks have not passed since the last dose was taken.
  • Has undergone weight loss/bariatric surgery (RYBG, gastric banding, sleeve gastrectomy, balloon, etc.) or is planning to undergo such surgery in the next 12 months (per self-report)
  • Phase 2 (child participant)
  • Has dietary restrictions, i.e., liquid diet, that may affect diet and study participation (per parent self-report)
  • Has physical activity restrictions, i.e., handicapped or mobility issues, that may affect physical activity participation (per parent self-report)
  • Has an eating disorder (per parent self-report)
  • Is underweight (per parent self-report)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Jennifer Leng, MD, MPH contact

646-888-8057

lengj@mskcc.org

Francesca Gany, MD, MS contact

646-888-8054

ganyf@mskcc.org

United States1 site, 1 recruiting
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities)

    New York, New York, 10065

    Jennifer Leng, MD, MPH, 646-888-8057

    Recruiting

Other trials in United States

About this study

The purpose of this study is to determine the most effective family-centered intervention (FCI) for weight loss and obesity prevention in Hispanic families. FCI is a type of program that involves family (such as parents and caregivers) supporting their children to promote healthy habits.

Being tested
Parent Weekly Individual Telephone Support, Child Education, Parent Initial Counseling, Parent Monthly Group Support
Keywords
child obesity, obesity, weight loss, Memorial Sloan Kettering Cancer Center, 25-003
Medical subject headings
Obesity, Pediatric Obesity, Weight Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Parent Weekly Individual Telephone SupportBehavioural

    Also called Tele

    Interventionists will deliver a 20-30 minute session via videoconference (e.g. Zoom) using the Family COMIDA Intervention Manual

  • Child EducationBehavioural

    6 weekly diet/PA education sessions ('Child Education')

  • Parent Initial CounselingBehavioural

    Also called Parent Counseling

    Interventionists will deliver a 20-30 minute session via videoconference (e.g. Zoom) using the Family COMIDA Intervention Manual

  • Parent Monthly Group SupportBehavioural

    Also called Group

    Parents will be invited to join a Spanish language (English if preferred) weekly group videoconference (can join by phone if preferred).

Study groups in NCT07144800
Study groupRoleWhat they receive
Condition 1: TeleExperimentalIntervention for 6 months more or less
Receives: Behavioral: Parent Weekly Individual Telephone Support
Condition 2: Child EducationExperimentalIntervention for 6 months
Receives: Behavioral: Child Education
Condition 3: Parent CounselingExperimentalIntervention for 6 months
Receives: Behavioral: Parent Initial Counseling
Condition 4: Counseling, Child Education, and TeleExperimentalIntervention for 6 months
Receives: Behavioral: Parent Weekly Individual Telephone Support; Behavioral: Child Education; Behavioral: Parent Initial Counseling
Condition 5: Group SupportExperimentalIntervention for 6 months
Receives: Behavioral: Parent Monthly Group Support
Condition 6: Group Support, Child Education, and TeleExperimentalIntervention for 6 months
Receives: Behavioral: Parent Weekly Individual Telephone Support; Behavioral: Child Education; Behavioral: Parent Monthly Group Support
Condition 7: Group Support, Parent Counseling, and TeleExperimentalIntervention for 6 months
Receives: Behavioral: Parent Weekly Individual Telephone Support; Behavioral: Parent Initial Counseling; Behavioral: Parent Monthly Group Support
Condition 8: Group Support, Parent Counseling, and Child EducationExperimentalIntervention for 6 months
Receives: Behavioral: Child Education; Behavioral: Parent Initial Counseling; Behavioral: Parent Monthly Group Support

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage weight loss from baseline among participants

    To utilize an optimization trial to identify the most effective, mHealth weight loss/obesity prevention FCI for Hispanic families in the U.S. 5% weight loss from baseline among overweight/obese parents (a percentage loss associated with numerous health benefits)

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Aug 2025
  2. Study start22 Aug 2025
  3. Primary completion31 Jul 2030 (estimated)
  4. Study completion31 Jul 2031 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
1,319 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07144800
Sponsor's protocol ID
25-003
Status last verified
Oct 2026
First submitted
25 Aug 2025
Last updated
8 Oct 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made following one year after publication and for up to 36 months later. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.

Publications

  • Leng J, Gonzalez-Sarinana LI, Minaya S, Narang B, Gilliland J, Gany F. Finding Balance: Insights from Mexican Heritage Families on Living a Healthy Lifestyle in New York City. J Community Health. 2026 Jul 23. doi: 10.1007/s10900-026-01607-5. Online ahead of print.

    PubMed 42493744

Questions about this trial

What is this clinical trial studying?

A study testing Parent Weekly Individual Telephone Support, Child Education and Parent Initial Counseling in people with Obesity and Child Obesity, run by Memorial Sloan Kettering Cancer Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 21 inclusion and 25 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 8 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jennifer Leng, MD, MPH (646-888-8057, lengj@mskcc.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage weight loss from baseline among participants (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07144800, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in